Terms: = Colorectal cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Treatment
856 results:
1. XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
Pan QZ; Zhao JJ; Liu L; Zhang DS; Wang LP; Hu WW; Weng DS; Xu X; Li YZ; Tang Y; Zhang WH; Li JY; Zheng X; Wang QJ; Li YQ; Xiang T; Zhou L; Yang SN; Wu C; Huang RX; He J; Du WJ; Chen LJ; Wu YN; Xu B; Shen Q; Zhang Y; Jiang JT; Ren XB; Xia JC
Signal Transduct Target Ther; 2024 Apr; 9(1):79. PubMed ID: 38565886
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and safety of Shenbai Granules for recurrent colorectal adenoma: A multicenter randomized controlled trial.
Ni M; Zhang Y; Sun Z; Zhou Q; Xiao J; Zhang B; Lin J; Gong B; Liu F; Meng F; Zheng G; Wang Y; Gu L; Li L; Shen W; Chen Y; Liu Y; Li L; Ling T; Cheng H
Phytomedicine; 2024 May; 127():155496. PubMed ID: 38471368
[TBL] [Abstract] [Full Text] [Related]
3. Mismatch repair status and surgical approach in apparent early-stage endometrial cancer.
Morton R; Webb PM; Na R; Obermair A; Farrell R
Int J Gynecol Cancer; 2024 Apr; 34(4):535-543. PubMed ID: 38431289
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration.
Piscitelli J; Reddy MB; Wollenberg L; Del Frari L; Gong J; Wood L; Zhang Y; Matschke K; Williams JH
Clin Pharmacokinet; 2024 Apr; 63(4):483-496. PubMed ID: 38424308
[TBL] [Abstract] [Full Text] [Related]
5. Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial.
van de Vlasakker VCJ; Guchelaar NAD; van den Heuvel TBM; Lurvink RJ; van Meerten E; Bax RJF; Creemers GM; van Hellemond IEG; Brandt-Kerkhof ARM; Madsen EVE; Nederend J; Koolen SLW; Nienhuijs SW; Kranenburg O; de Hingh IHJT; Verhoef C; Mathijssen RHJ; Burger JWA; ;
BMJ Open; 2024 Jan; 14(1):e077667. PubMed ID: 38238055
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical application effect of pedunculated rectus abdominis muscle combined with bilateral ureters for repairing refractory bladder-vaginal stump fistula through external vesical drainage].
Wang GC; Wang GY; Zhao J; Guo LL; Tian KK; Wang T; Gao CQ; Li LJ; Liu YJ; Zhang GQ; Wang YC; Ding LL; Zhang Z; Wang C; Qi ZC
Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1077-1080. PubMed ID: 38110316
[No Abstract] [Full Text] [Related]
7. A phase I study of intra-anal artesunate (suppositories) to treat anal high-grade squamous intraepithelial lesions.
Fang SH; Plesa M; Carchman EH; Cowell NA; Staudt E; Twaroski KA; Buchwald UK; Trimble CL
PLoS One; 2023; 18(12):e0295647. PubMed ID: 38100463
[TBL] [Abstract] [Full Text] [Related]
8. A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic colorectal cancer.
Lee KW; Han SW; Kim TW; Ahn JB; Baek JY; Cho SH; Lee H; Kim JW; Kim JW; Kim TY; Hong YS; Beom SH; Cha Y; Choi Y; Kim S; Bang YJ
Cancer Res Treat; 2024 Apr; 56(2):590-601. PubMed ID: 38062706
[TBL] [Abstract] [Full Text] [Related]
9. A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line treatment of Metastatic colorectal cancer: The AGENT Trial.
Tabernero J; Yoshino T; Stintzing S; de Gramont A; Gibbs P; Jonker DJ; Nygren P; Papadimitriou C; Prager GW; Tell R; Lenz HJ
Cancer Res Commun; 2024 Jan; 4(1):28-37. PubMed ID: 38059497
[TBL] [Abstract] [Full Text] [Related]
10. Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.
Desai J; Alonso G; Kim SH; Cervantes A; Karasic T; Medina L; Shacham-Shmueli E; Cosman R; Falcon A; Gort E; Guren T; Massarelli E; Miller WH; Paz-Ares L; Prenen H; Amatu A; Cremolini C; Kim TW; Moreno V; Ou SI; Passardi A; Sacher A; Santoro A; Stec R; Ulahannan S; Arbour K; Lorusso P; Luo J; Patel MR; Choi Y; Shi Z; Mandlekar S; Lin MT; Royer-Joo S; Chang J; Jun T; Dharia NV; Schutzman JL; ; Han SW
Nat Med; 2024 Jan; 30(1):271-278. PubMed ID: 38052910
[TBL] [Abstract] [Full Text] [Related]
11. Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors.
Bauer TM; Santoro A; Lin CC; Garrido-Laguna I; Joerger M; Greil R; Spreafico A; Yau T; Goebeler ME; Hütter-Krönke ML; Perotti A; Juif PE; Lu D; Barys L; Cremasco V; Pelletier M; Evans H; Fabre C; Doi T
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38030303
[TBL] [Abstract] [Full Text] [Related]
12. Clinical, Functional, and Nutritional Efficacy of a Glutamine-Enriched Oligomeric Diet in Patients with Rectal cancer.
Peña Vivas JDC; Orduz Arena AC; Alonso García A; Carrascal Gordillo CF; Martínez Gutiérrez R; Rodríguez-Acosta Caballero C; Fernández Freije I; Paino Martínez AB; Belloso Cuesta T; Juan Rijo G; Calleja Fernández A
Nutr Cancer; 2024; 76(1):128-136. PubMed ID: 37994411
[TBL] [Abstract] [Full Text] [Related]
13. Psoralea corylifolia formula extract-loaded silk fibroin/polycaprolactone fibrous membrane for the treatment of colorectal cancer.
Feng Y; Han Z; Chen C; Wang X; Liu J; Khan Y; Xie M; Chen Y; Zhang Y; Li G
Colloids Surf B Biointerfaces; 2024 Jan; 233():113635. PubMed ID: 37976725
[TBL] [Abstract] [Full Text] [Related]
14. cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in cancer Burden, 2020-2050: A Statistical Modeling Study.
Nguyen PT; Hori M; Matsuda T; Katanoda K
Cancer Epidemiol Biomarkers Prev; 2023 Dec; 32(12):1756-1770. PubMed ID: 37756571
[TBL] [Abstract] [Full Text] [Related]
15. A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer.
Day D; Park JJ; Coward J; Markman B; Lemech C; Kuo JC; Prawira A; Brown MP; Bishnoi S; Kotasek D; Strother RM; Cosman R; Su R; Ma Y; Yue Z; Hu HH; Wu R; Li P; Tse AN
Br J Cancer; 2023 Nov; 129(10):1608-1618. PubMed ID: 37731023
[TBL] [Abstract] [Full Text] [Related]
16. Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type colorectal cancer.
Jiang DM; Parshad S; Zhan L; Sim HW; Siu LL; Liu G; Shapiro JD; Price TJ; Jonker DJ; Karapetis CS; Strickland AH; Zhang W; Jeffery M; Tu D; Ng S; Sabesan S; Shannon J; Townsend A; O'Callaghan CJ; Chen EX
Clin Colorectal Cancer; 2023 Dec; 22(4):457-463. PubMed ID: 37704538
[TBL] [Abstract] [Full Text] [Related]
17. Ulcerative Colitis in Adults: A Review.
Gros B; Kaplan GG
JAMA; 2023 Sep; 330(10):951-965. PubMed ID: 37698559
[TBL] [Abstract] [Full Text] [Related]
18. Patient-reported unmet supportive care needs in long-term colorectal cancer survivors after curative treatment in an Asian population.
Lin W; Yoon S; Zhao Y; Seow-En I; Chok AY; Tan EKW
Asian J Surg; 2024 Jan; 47(1):256-262. PubMed ID: 37659941
[TBL] [Abstract] [Full Text] [Related]
19. Chinese herbal medicine for irinotecan-induced diarrhea: A systematic review and meta-analysis.
Lin X; Fang Y; Cheng Y; Wang Q
Explore (NY); 2024; 20(2):158-167. PubMed ID: 37640591
[TBL] [Abstract] [Full Text] [Related]
20. Single-Agent Divarasib (GDC-6036) in Solid Tumors with a
Sacher A; LoRusso P; Patel MR; Miller WH; Garralda E; Forster MD; Santoro A; Falcon A; Kim TW; Paz-Ares L; Bowyer S; de Miguel M; Han SW; Krebs MG; Lee JS; Cheng ML; Arbour K; Massarelli E; Choi Y; Shi Z; Mandlekar S; Lin MT; Royer-Joo S; Chang J; Dharia NV; Schutzman JL; Desai J;
N Engl J Med; 2023 Aug; 389(8):710-721. PubMed ID: 37611121
[TBL] [Abstract] [Full Text] [Related]
[Next]
